• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于修订前列腺癌患者报告结局指标分析中量表成员资格的症状群:医学研究委员会RT01试验(ISCRTN47772397)的二次数据分析

Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397).

作者信息

Lemanska Agnieszka, Chen Tao, Dearnaley David P, Jena Rajesh, Sydes Matthew R, Faithfull Sara

机构信息

Faculty of Health and Medical Sciences, School of Health Sciences, University of Surrey, Guildford, UK.

Department of Chemical and Process Engineering, University of Surrey, Guildford, UK.

出版信息

Qual Life Res. 2017 Aug;26(8):2103-2116. doi: 10.1007/s11136-017-1548-y. Epub 2017 Mar 28.

DOI:10.1007/s11136-017-1548-y
PMID:28352980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5509840/
Abstract

PURPOSE

To investigate the role of symptom clusters in the analysis and utilisation of patient reported outcome measures (PROMs) for data modelling and clinical practice. To compare symptom clusters with scales, and to explore their value in PROMs interpretation and symptom management.

METHODS

A dataset called RT01 (ISCRTN47772397) of 843 prostate cancer patients was used. PROMs were reported with the University of California, Los Angeles Prostate Cancer Index (UCLA-PCI). Symptom clusters were explored with hierarchical cluster analysis (HCA) and average linkage method (correlation > 0.6). The reliability of the Urinary Function Scale was evaluated with Cronbach's Alpha. The strength of the relationship between the items was investigated with Spearman's correlation. Predictive accuracy of the clusters was compared to the scales by receiver operating characteristic (ROC) analysis. Presence of urinary symptoms at 3 years measured with the late effects on normal tissue: subjective, objective, management tool (LENT/SOM) was an endpoint.

RESULTS

Two symptom clusters were identified (urinary cluster and sexual cluster). The grouping of symptom clusters was different than UCLA-PCI Scales. Two items of the urinary function scales ("number of pads" and "urinary leak interfering with sex") were excluded from the urinary cluster. The correlation with the other items in the scale ranged from 0.20 to 0.21 and 0.31 to 0.39, respectively. Cronbach's Alpha showed low correlation of those items with the Urinary Function Scale (0.14-0.36 and 0.33-0.44, respectively). All urinary function scale items were subject to a ceiling effect. Clusters had better predictive accuracy, AUC = 0.70 -0.65, while scales AUC = 0.67-0.61.

CONCLUSION

This study adds to the knowledge on how cluster analysis can be applied for the interpretation and utilisation of PROMs. We conclude that multiple-item scales should be evaluated and that symptom clusters provide a study-specific approach for modelling and interpretation of PROMs.

摘要

目的

探讨症状群在患者报告结局测量指标(PROMs)的分析及用于数据建模和临床实践中的作用。比较症状群与量表,并探究它们在PROMs解释及症状管理中的价值。

方法

使用了一个名为RT01(ISCRTN47772397)的数据集,其中包含843例前列腺癌患者。PROMs通过加利福尼亚大学洛杉矶分校前列腺癌指数(UCLA-PCI)进行报告。采用层次聚类分析(HCA)和平均连锁法(相关性>0.6)探索症状群。用Cronbach's Alpha评估尿功能量表的信度。用Spearman相关性研究各条目之间关系的强度。通过受试者工作特征(ROC)分析比较症状群与量表的预测准确性。以正常组织晚期效应:主观、客观、管理工具(LENT/SOM)测量的3年时泌尿症状的存在情况作为一个终点。

结果

识别出两个症状群(泌尿症状群和性症状群)。症状群的分组与UCLA-PCI量表不同。尿功能量表的两个条目(“尿垫数量”和“影响性生活的尿失禁”)被排除在泌尿症状群之外。它们与量表中其他条目的相关性分别为0.20至0.21和0.31至0.39。Cronbach's Alpha显示这些条目与尿功能量表的相关性较低(分别为0.14 - 0.36和0.33 - 0.44)。所有尿功能量表条目均存在天花板效应。症状群具有更好的预测准确性,曲线下面积(AUC)=0.70 - 0.65,而量表的AUC =0.67 - 0.61。

结论

本研究增加了关于如何将聚类分析应用于PROMs的解释和利用的知识。我们得出结论,应评估多条目量表,并且症状群为PROMs的建模和解释提供了一种针对特定研究的方法。

相似文献

1
Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397).用于修订前列腺癌患者报告结局指标分析中量表成员资格的症状群:医学研究委员会RT01试验(ISCRTN47772397)的二次数据分析
Qual Life Res. 2017 Aug;26(8):2103-2116. doi: 10.1007/s11136-017-1548-y. Epub 2017 Mar 28.
2
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.规范局部前列腺癌患者报告结局测量的评估。系统评价。
Eur Urol Oncol. 2022 Apr;5(2):153-163. doi: 10.1016/j.euo.2021.10.004. Epub 2021 Nov 14.
3
Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer.老年、早期症状和身体功能与接受前列腺癌放射治疗的男性晚期症状群严重程度相关。
Clin Oncol (R Coll Radiol). 2018 Jun;30(6):334-345. doi: 10.1016/j.clon.2018.01.016. Epub 2018 Feb 17.
4
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.前列腺癌中高剂量与标准剂量适形放疗的比较:MRC RT01随机对照试验的初步结果
Lancet Oncol. 2007 Jun;8(6):475-87. doi: 10.1016/S1470-2045(07)70143-2.
5
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.扩展前列腺癌指数综合量表(EPIC)的开发与验证,用于全面评估前列腺癌男性患者的健康相关生活质量。
Urology. 2000 Dec 20;56(6):899-905. doi: 10.1016/s0090-4295(00)00858-x.
6
Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.将加州大学洛杉矶分校经皮冠状动脉介入治疗(PCI)与扩展前列腺癌指数综合指标相联系的分析:对日本局限性前列腺癌男性患者健康相关生活质量的评估
J Urol. 2007 Aug;178(2):473-7; discussion 477. doi: 10.1016/j.juro.2007.03.113. Epub 2007 Jun 11.
7
Cross-cultural validation of the UCLA prostate cancer index.加州大学洛杉矶分校前列腺癌指数的跨文化验证
Urology. 2003 Feb;61(2):302-7. doi: 10.1016/s0090-4295(02)02245-8.
8
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.前列腺癌临床局限性治疗的ProtecT随机试验中的患者报告结局:研究设计、基线泌尿、肠道及性功能和生活质量
BJU Int. 2016 Dec;118(6):869-879. doi: 10.1111/bju.13582. Epub 2016 Aug 17.
9
Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).早期前列腺癌调强适形放疗后迟发性胃肠道毒性:来自英国医学研究理事会 RT01 试验(ISRCTN47772397)的结果。
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):773-83. doi: 10.1016/j.ijrobp.2009.05.052. Epub 2009 Oct 14.
10
Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis.对接受根治性手术的前列腺癌男性患者报告结局指标的评估:一项拉施分析。
BMJ Open. 2020 Nov 14;10(11):e035436. doi: 10.1136/bmjopen-2019-035436.

引用本文的文献

1
Development and validation of a patient reported outcome measure for health-related quality of life for locally recurrent rectal cancer: a multicentre, three-phase, mixed-methods, cohort study.局部复发性直肠癌患者健康相关生活质量的患者报告结局指标的开发与验证:一项多中心、三阶段、混合方法队列研究。
EClinicalMedicine. 2023 May 17;59:101945. doi: 10.1016/j.eclinm.2023.101945. eCollection 2023 May.
2
Moving beyond Table 1: A critical review of the literature addressing social determinants of health in chronic condition symptom cluster research.超越表 1:对慢性疾病症状群研究中健康社会决定因素文献的批判性回顾。
Nurs Inq. 2023 Jan;30(1):e12519. doi: 10.1111/nin.12519. Epub 2022 Oct 25.
3

本文引用的文献

1
Cancer Symptom Cluster Management.癌症症状群管理
Semin Oncol Nurs. 2016 Nov;32(4):373-382. doi: 10.1016/j.soncn.2016.08.004. Epub 2016 Oct 24.
2
Responsiveness and ceiling effects of the Forgotten Joint Score-12 following total hip arthroplasty.全髋关节置换术后遗忘关节评分-12的反应性和天花板效应。
Bone Joint Res. 2016 Mar;5(3):87-91. doi: 10.1302/2046-3758.53.2000480.
3
Patient-reported Outcome Measures in Radiotherapy: Clinical Advances and Research Opportunities in Measurement for Survivorship.放疗中患者报告的结局指标:生存测量的临床进展与研究机遇
How is quality of life defined and assessed in published research?
发表的研究中如何定义和评估生活质量?
Qual Life Res. 2021 Aug;30(8):2109-2121. doi: 10.1007/s11136-021-02826-0. Epub 2021 Apr 1.
4
Symptom and function profiles of men with localized prostate cancer.局限性前列腺癌患者的症状和功能特征。
Cancer. 2018 Jul 1;124(13):2832-2840. doi: 10.1002/cncr.31401. Epub 2018 Apr 16.
5
Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer.老年、早期症状和身体功能与接受前列腺癌放射治疗的男性晚期症状群严重程度相关。
Clin Oncol (R Coll Radiol). 2018 Jun;30(6):334-345. doi: 10.1016/j.clon.2018.01.016. Epub 2018 Feb 17.
Clin Oncol (R Coll Radiol). 2015 Nov;27(11):679-85. doi: 10.1016/j.clon.2015.07.007. Epub 2015 Sep 28.
4
Floor and ceiling effects in the OHS: an analysis of the NHS PROMs data set.职业健康状况调查中的地板效应和天花板效应:对英国国家医疗服务体系患者报告结局测量数据集的分析
BMJ Open. 2015 Jul 27;5(7):e007765. doi: 10.1136/bmjopen-2015-007765.
5
Population-based study of long-term functional outcomes after prostate cancer treatment.基于人群的前列腺癌治疗后长期功能结局研究。
BJU Int. 2016 Jun;117(6B):E36-45. doi: 10.1111/bju.13179. Epub 2015 Jun 23.
6
Integrated care pathways for cancer survivors - a role for patient-reported outcome measures and health informatics.癌症幸存者的综合护理路径——患者报告结局测量与健康信息学的作用
Acta Oncol. 2015 May;54(5):600-8. doi: 10.3109/0284186X.2014.995778. Epub 2015 Mar 9.
7
Transitions in Symptom Cluster Subgroups Among Men Undergoing Prostate Cancer Radiation Therapy.接受前列腺癌放射治疗的男性患者症状簇亚组的转变
Cancer Nurs. 2016 Jan-Feb;39(1):3-11. doi: 10.1097/NCC.0000000000000236.
8
The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.REQUITE项目:验证放疗毒性的预测模型和生物标志物,以减少癌症幸存者的副作用并提高生活质量。
Clin Oncol (R Coll Radiol). 2014 Dec;26(12):739-42. doi: 10.1016/j.clon.2014.09.008. Epub 2014 Sep 27.
9
Defining a standard set of patient-centered outcomes for men with localized prostate cancer.定义一组以患者为中心的局部前列腺癌男性患者结局的标准。
Eur Urol. 2015 Mar;67(3):460-7. doi: 10.1016/j.eururo.2014.08.075. Epub 2014 Sep 16.
10
Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs).患者报告结局(PROs)和患者报告结局测量指标(PROMs)。
Health Serv Insights. 2013 Aug 4;6:61-8. doi: 10.4137/HSI.S11093. eCollection 2013.